(Q80417435)
Statements
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase (English)
P Airò
E Danieli
M Rossi
M Frassi
I Cavazzana
M Scarsi
A Grottolo
F Franceschini